 Piper Sandler noted that Arcturus Therapeutics Holdings Incs NASDAQ: ARCT recently filed 10-K mentions funding of 25 million from a pharmaceutical company to run a clinical trial for LUNAR-COV19 vaccine candidate as a booster. According to analyst Yasmeen. 